![Robert C. Stoner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert C.
Stoner held former positions as Vice President of Human Resources at BioCryst Pharmaceuticals, Inc., Senior Vice President of Human Resources at Smith Breeden Associates, Inc., and Vice President of Human Resources at EMD Pharmaceuticals, Inc. He obtained an undergraduate degree from Southern Illinois University.
| Sociétés | Poste | Fin |
|---|---|---|
Smith Breeden Associates, Inc.
 Smith Breeden Associates, Inc. Investment ManagersFinance Smith Breeden Associates employs a variety of investment strategies including indexing, hedging, social screening and quantitative. Though not limited by sector or market-cap, the firm tends to invest in the stocks of companies in the finance, energy minerals, electronic technology, healthcare technology and consumer non-durables sectors. They invest globally, across all market-caps, with emphasis on the stocks of large-cap companies. SBA's fixed-income approach seeks to determine a fixed-income security's relative value. The firm employs quantitative research to identify high credit quality investments with the potential to generate risk-adjusted returns in excess of market returns. Their primary determinant of relative value is the option-adjusted spread to US Treasuries. The firm's fixed-income investment strategy is designed to generate a consistent and predictable return over the client's preferred benchmark. SBA's strategy emphasizes sector and security selection, duration targeting and high credit quality. The firm uses proprietary models to project mortgage prepayments, to identify price options embedded in agency MBS and corporate bonds, to price corporate bond credit risk, as well as to predict the future returns of major asset classes. | Responsable des Ressources Humaines | - |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Responsable des Ressources Humaines | - |
| BIOCRYST PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Smith Breeden Associates, Inc.
Smith Breeden Associates, Inc. Investment ManagersFinance Smith Breeden Associates employs a variety of investment strategies including indexing, hedging, social screening and quantitative. Though not limited by sector or market-cap, the firm tends to invest in the stocks of companies in the finance, energy minerals, electronic technology, healthcare technology and consumer non-durables sectors. They invest globally, across all market-caps, with emphasis on the stocks of large-cap companies. SBA's fixed-income approach seeks to determine a fixed-income security's relative value. The firm employs quantitative research to identify high credit quality investments with the potential to generate risk-adjusted returns in excess of market returns. Their primary determinant of relative value is the option-adjusted spread to US Treasuries. The firm's fixed-income investment strategy is designed to generate a consistent and predictable return over the client's preferred benchmark. SBA's strategy emphasizes sector and security selection, duration targeting and high credit quality. The firm uses proprietary models to project mortgage prepayments, to identify price options embedded in agency MBS and corporate bonds, to price corporate bond credit risk, as well as to predict the future returns of major asset classes. | Finance |
Southern Illinois University
 Southern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
